FIELD: medicine.
SUBSTANCE: invention relates to molecular oncology. A test system is presented. The test system contains reagents for obtaining cDNA on a total RNA matrix using a reverse transcription reaction combined with polyadenylation, amplification of the cDNA library in real time. The test system contains highly specific primers for hsa-miR-7-5p, hsa-miR-26a-5p and hsa-miR-143-3p. It provides primary data on the relative expression of micro-RNA in blood plasma for the calculation of prognostic coefficients KmiR-26a and KmiR-143, which make it possible to assess the likelihood of the course of the disease with or without the development of remote/regional metastases. The test system has a high sensitivity and specificity, its use is possible with blood plasma.
EFFECT: test system provides a minimally invasive assessment of the likelihood of metastasis in patients with colorectal cancer, which makes it possible to personalize treatment tactics.
1 cl, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PREDICTING THE DEVELOPMENT OF RELAPSE IN PATIENTS WITH HUMAN PAPILLOMAVIRUS AND NON-MUSCLE-INVASIVE BLADDER CANCER | 2022 |
|
RU2800265C1 |
| QUANTITATIVE ESTIMATE has-miR-16-5p, has-miR-425-5p, has-miR-17-5p, has-miR-20a-5p, has-miR-101-3p, has-miR-30D-5p AND has-miR-93-5p IN PERIPHERAL BLOOD PLASMA OF WOMEN AS METHOD FOR NON-INVASIVE DIAGNOSIS OF SEROUS BOUNDARY OVARY ADENOCYSTOMA AND CYSTADENOCARCENOMA | 2018 |
|
RU2688169C1 |
| METHOD FOR MINIMALLY INVASIVE DIAGNOSIS OF MENINGIOMAS AND GLIAL TUMORS WITH SPECIFICATION OF THE DEGREE OF MALIGNANCY | 2022 |
|
RU2788814C1 |
| ANALYTICAL SYSTEM FOR DIAGNOSING LUNG CANCER USING FREE AND CIRCULATING MICRO-RNAS ASSOCIATED WITH BLOOD CELLS | 2020 |
|
RU2755651C1 |
| METHOD FOR PREDICTING RECURRENCE OF SEROUS OVARIAN CARCINOMA | 2020 |
|
RU2749361C1 |
| QUANTIFICATION OF THE hsa-miR-30c-5/VIM, hsa-miR-28-3p/VIM, hsa-miR-1-3p/ANXA2, hsa-miR-30c-5p/FBN1, hsa-miR-15b-5p/MYL6 tr.v.1, hsa-miR-15b-5p/MYL6 tr.v.2, hsa-miR-185-3p/FLNA, hsa-miR-1-3p/YWHAZ, hsa-miR-30c-5p/YWHAZ AND hsa-miR-654-3p/FGA RATIO IN THE PLACENTAL SITE OF WOMEN ON THE DAY OF DELIVERY AT A TERM OF MORE THAN 34 WEEKS OF GESTATION AS A METHOD FOR DIFFERENTIAL DIAGNOSIS OF FETAL GROWTH RESTRICTION SYNDROME, PREECLAMPSIA AND A SMALL FOR GESTATIONAL AGE FETUS SYNDROME | 2021 |
|
RU2771205C1 |
| METHOD FOR DIAGNOSING GLIAL BRAIN TUMORS OF HIGH DEGREE OF MALIGNANCY | 2020 |
|
RU2742413C1 |
| METHOD FOR ASSESSING RESISTANCE OF SQUAMOUS CELL CANCER OF THROAT TO RADIATION THERAPY AND SET OF TESTS FOR IMPLEMENTATION THEREOF | 2022 |
|
RU2818356C1 |
| METHOD FOR DETERMINING THE RADIOSENSITIVITY OF MALIGNANT RECTAL TUMOURS | 2020 |
|
RU2754154C1 |
| BIOMARKERS OF TRAUMATIC BRAIN INJURY | 2017 |
|
RU2771757C2 |
